1. Home
  2. blog

Whoop raises $575 million at $10.1 billion valuation

Whoop raised $575 million at a $10.1 billion valuation in a round led by Collaborative Fund, with participation from the Qatar Investment Authority and athletes LeBron James and Cristiano Ronaldo. The company makes a 24/7 wristband that tracks HRV, blood pressure and blood oxygen and has shifted from an elite-athlete focus toward broader consumer health.

31 Mar 2026

Market report projects closed-loop neuromodulation processors will reach $4.63 billion by 2030

The Business Research Company forecasts the closed-loop neuromodulation processor market will reach $4.63 billion by 2030 (12.9% CAGR), citing AI-driven adaptive processors, wearable controllers and telemedicine integration; the report also highlights Medtronic's Feb 2025 FDA approvals and a 2023 Amber–Bioinduction acquisition.

28 Mar 2026

Paradromics launches APEX partnership program to pair Connexus BCI with academic labs

Paradromics launched an APEX Partnership Program to connect academic BCI researchers with its Connexus implantable interface; the FDA-approved Connect-One study aims to begin the first surgery in H1 2026.

28 Mar 2026

Cognito Therapeutics partners with Ochsner to test Spectris neuromodulation in the Gulf South

Cognito Therapeutics has joined Ochsner Health to pilot its investigational Spectris system—gamma-frequency light and sound neuromodulation—across the Gulf South, aiming to develop a Brain Health Index and gather real-world clinical and health-economics data.

27 Mar 2026

EMOTIV publishes Ubuntu beta of its Launcher app for EEG headsets

EMOTIV has published an Ubuntu beta of its Launcher app, providing a single-login hub for EMOTIV EEG headsets and apps with raw-data capture, BCI controls, device management, and a Virtual Brainwear simulator.

27 Mar 2026

Avation Medical Names Manish Vaishya, PhD as CEO and Closes Series D Financing

Avation Medical appoints co-founder Manish Vaishya, PhD as CEO and closes Series D financing to scale commercialization and reimbursement for its FDA-cleared Vivally wearable neuromodulation system for overactive bladder.

24 Mar 2026

Nexstim NBS System 6 Gains FDA Clearance for Treatment of Obsessive–Compulsive Disorder (OCD)

Nexstim's NBS System 6 received FDA clearance for adjunctive treatment of adult OCD in the U.S.; the navigated E-field TMS system remains cleared for MDD and pre-surgical mapping and emphasizes MRI-based individualized targeting and a modular, software-guided workflow.

24 Mar 2026

Resonetics Completes Acquisition of Resolution Medical, Expands Integrated Capabilities for Interventional and Neuromodulation Markets

Resonetics acquires Resolution Medical to expand integrated design, battery, and manufacturing capabilities for neuromodulation and interventional medical de...

23 Mar 2026

Mave Health Secures $2.1 Million To Expand Neurotech Wearable

Mave Health raised $2.1M to launch a tDCS wearable for stress, focus and brain health in the US and India; shipping starts April 2026.

23 Mar 2026

Meta Funds University Teams To Explore Wider Applications Of sEMG Wristband Input

Meta awards six universities $150K each to study wrist sEMG for speech, accessibility, training, privacy, and higher-bandwidth wearable input.

23 Mar 2026
1 2 3 →

Search

About Us

Stay updated with the latest events and innovations from BrainPatch.ai by following our news and updates!

Categories

Archives